# Amr Makady

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/amr-makady/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,981 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 16 |
| i10-index | 22 |
| OpenAlex ID | https://openalex.org/A5017552574 |
| ORCID iD | 0000-0002-5260-1946 |
| Works | 46 |

## Researcher papers

- [Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making](https://scholariq.org/papers/good-practices-for-real-world-data-studies-of-treatment-and-or-comparative/)
- [What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews](https://scholariq.org/papers/what-is-real-world-data-a-review-of-definitions-based-on-literature-and/)
- [Good practices for real‐world data studies of treatment and/or comparative effectiveness: Recommendations from the joint <scp>ISPOR‐ISPE</scp> Special Task Force on real‐world evidence in health care decision making](https://scholariq.org/papers/good-practices-for-real-world-data-studies-of-treatment-and-or-comparative-2/)
- [Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies](https://scholariq.org/papers/policies-for-use-of-real-world-data-in-health-technology-assessment-hta-a/)
- [Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions](https://scholariq.org/papers/reproducibility-of-real-world-evidence-studies-using-clinical-practice-data-to/)
- [Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies](https://scholariq.org/papers/using-real-world-data-in-health-technology-assessment-hta-practice-a-comparative/)
- [Implementing managed entry agreements in practice: The Dutch reality check](https://scholariq.org/papers/implementing-managed-entry-agreements-in-practice-the-dutch-reality-check/)
- [TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases](https://scholariq.org/papers/trust4rd-tool-for-reducing-uncertainties-in-the-evidence-generation-for/)
- [Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines](https://scholariq.org/papers/regulatory-and-health-technology-assessment-advice-on-postlicensing-and/)
- [Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia](https://scholariq.org/papers/use-of-medicine-pricing-and-reimbursement-policies-for-universal-health-coverage/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Meta-analysis and systematic reviews](https://scholariq.org/topics/meta-analysis-and-systematic-reviews/)
- [Health Policy Implementation Science](https://scholariq.org/topics/health-policy-implementation-science/)
- [Advanced Causal Inference Techniques](https://scholariq.org/topics/advanced-causal-inference-techniques/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.